Realta Investment Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Realta Investment Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-25,397	Closed	-$2.51M	–	368
2020 Q2	$2.51M	Sell	25,397 -587	-2%	-$46.8K	0.83%	18
2020 Q1	$1.67M	Sell	25,984 -624	-2%	-$43.7K	0.72%	26
2019 Q4	$1.83M	Buy	26,608 +344	+1%	+$21.2K	0.5%	30
2019 Q3	$1.55M	Buy	26,264 +6,260	+31%	+$400K	0.42%	39
2019 Q2	$1.29M	Buy	20,004 +3,108	+18%	+$201K	0.36%	49
2019 Q1	$1.08M	Buy	+16,896	New	+$888K	0.49%	35

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Realta Investment Advisors's TNDM Position: Q3 2020 in Review

Realta Investment Advisors sold out of Tandem Diabetes Care (TNDM) in Q3 2020, closing a stake of 25,397 shares — an estimated $2.51M sold.

Realta Investment Advisors first reported a position in TNDM in Q1 2019 and held it in 6 quarters. The position peaked at $2.51M in Q2 2020. 321 funds tracked by Wall St. Rank hold TNDM as of Q3 2020.

Realta Investment Advisors reported no remaining Tandem Diabetes Care position as of Q3 2020 after selling out during the quarter.
Realta Investment Advisors sold 25,397 Tandem Diabetes Care shares in Q3 2020, an estimated $2.51M.
Realta Investment Advisors first reported a position in Tandem Diabetes Care in Q1 2019 and held it in 6 quarters.
Realta Investment Advisors's Tandem Diabetes Care position peaked at $2.51M in Q2 2020.
321 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2020.

Based on Realta Investment Advisors's 13F filing for Q3 2020, filed 23 Oct 2020.